Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Myovant Sciences Ltd (NY: MYOV )

18.15 USD -0.21 (-1.14%)
Official Closing Price Updated: 7:50 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,014,800
Open 18.24
Bid (Size) 18.09 (1)
Ask (Size) 18.90 (1)
Prev. Close 18.36
Today's Range 17.85 - 18.71
52wk Range 8.680 - 30.90
Shares Outstanding 14,500,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Myovant Sciences Appoints Lauren Merendino as Chief Commercial Officer
From GlobeNewswire News Releases
Myovant Sciences Announces European Medicines Agency Validation of Marketing Authorization Application for Relugolix for the Treatment of Advanced Prostate Cancer
From GlobeNewswire News Releases

Performance

YTD
-26.90%
-26.90%
1 Month
-17.95%
-17.95%
3 Month
-23.64%
-23.64%
6 Month
+17.78%
+17.78%
1 Year
+89.06%
+89.06%

More News

Read More
Myovant Sciences and Pfizer Announce Positive Data from Phase 3 LIBERTY Randomized Withdrawal Study of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids
From GlobeNewswire News Releases
Myovant Sciences Announces Recipients of “Forward for Health Equity” Grants to Improve Healthcare Access in Prostate Cancer and Uterine Fibroids
From GlobeNewswire News Releases
Myovant Sciences to Present at Upcoming Investor Conferences
From GlobeNewswire News Releases
Sumitovant Biopharma Announces Publication in the New England Journal of Medicine of Myovant Sciences Phase 3 LIBERTY Studies of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids
From GlobeNewswire News Releases
Myovant Sciences and Pfizer Announce Publication in the New England Journal of Medicine of Phase 3 LIBERTY Studies of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids
From GlobeNewswire News Releases
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
From GlobeNewswire News Releases
HealthyWomen and Myovant Sciences Launch “Voices of Periods” to Fight Menstrual Stigma
From GlobeNewswire News Releases
Myovant Sciences Announces Corporate Updates and Financial Results for Third Quarter of Fiscal Year 2020
From GlobeNewswire News Releases
Look Under The Hood: PWC Has 10% Upside
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.